It seems that the day all Indians have been waiting for, for over six months seems to be nearing very soon. According to reports, India is all set to get its first corona-virus vaccine.
The first vaccine in the country is likely to be the Oxford University/AstraZeneca vaccine, dubbed Covishield in India. The vaccine is likely to be commercialised in 73 days from now, a top official at the Serum Institute of India said.
According to Reports it is also said that Covishield is likely to be free for Indians
The Government of India has already indicated to the biotechnology company that it will directly procure the vaccines and is planning to distribute the vaccine for free among all Indians. The government has reportedly sought for 68 crore doses for 130 crore Indian citizens from SII by June next year.
Trials of Covishield are currently underway in the country and are being handled by the Serum Institute, official partners for the production and marketing of the vaccine in India. Previously, reports of the vaccine being the first to go into production in India had surfaced.
According to a report, an official from the SII has said that the government has granted a special manufacturing priority license to the biotechnology company and has fast-tracked the trial protocol processes to get the trials completed within 58 days.
Phase-3 Trials of Vaccine Began On 22nd August
An Official on Saturday said,"By this, the first dosing will take place today [Saturday] in the final phase [Phase III] and the second dosing will happen after 29 days. The final trial report will be out in another 15 days from the second dosing. By that time, we are planning to commercialise Covishield."
Phase 3 trials of Covishield in India began on the 22nd of August at 20 centres including Pune, Mumbai, and Ahmedabad. The vaccine will be administered to as many as 1600 people from different age groups to check the efficacy and safety of the vaccine in a large range of people.
Three vaccines – Covishield by SII, Covaxin by Bharat Biotech, and Zy-CoV-D by Zydus Caldia are currently under trials in India. In his speech on Independence Day, Prime Minister Modi said that the blueprint for production and distribution of the vaccine is prepared, and production of a COVID-19 vaccine will begin as soon as they receive a nod from the scientists.
The vaccine will reportedly belong to SII, as the company has entered into an exclusive agreement with AstraZeneca to buy rights and pay a royalty fee for exclusively selling the vaccine in India and 92 other countries.
1 Comments
It is a great news for all.
ReplyDelete